Otava Research Institute

Cathepsin K Targeted Library for offer

Posted by Nadiia from Otava Research InstituteResponsive · Innovative Products and Technologies · Ukraine

Summary of the technology

We offer the Cathepsin K Targeted Library. It contains 761 compounds with predicted inhibitory activity against this protease and suitable for the early stage of drug discovery

Otava Research Institute

Description of the technology

Cathepsin K (CTSK, CTS02, CTSO, CTSO1, CTSO2, PKND, PYCD) is a lysosomal cysteine protease involved in bone remodeling and resorption. It has a major role in osteoporosis and other bone-related pathologies, cancer, diabetes, obesity and atherosclerosis. Cathepsin K inhibitors show great potential in the treatment of such diseases.

We offer the Cathepsin K Targeted Library. It contains 761 compounds with predicted inhibitory activity against this protease and suitable for the early stage of drug discovery. The library has been designed with receptor-based virtual screening using crystal structure of CTSK (PDB ID: 4X6I). The overall procedure included accurate flexible docking of Drug-like Green Collection into cathepsin K binding pocket. Final selection of compounds has been made with inspection of CTSK active site’s crucial structural determinants for ligand binding, docking scores and intermolecular hydrogen bonds with key active site’s amino acid residues.

Technology Owner

Otava Research Institute

Research Institute

Related keywords

  • Biological Sciences
  • Medicine, Human Health
  • Biostatistics, Epidemiology
  • Virus, Virology / Antibiotics / Bacteriology
  • Infectious Diseases
  • Pharmaceutical Products / Drugs
  • Pharmaceutics
  • Pharmaceuticals/fine chemicals
  • compounds
  • library compounds
  • cathepsin k
  • drug discovery

About Otava Research Institute

Research Institute from Ukraine

Otava Institute is a global provider of one-stop integrated research solutions for business and life science. Our team includes chemists, biologists, physicists whose combined efforts contribute to the complex contract research projects for pharmaceutical, agro, cosmetic and material science industries.We are dedicated to providing clients with outstanding service in these key areas and will continue to push boundaries to remain an industry front-runner. Each day we expand our core competencies delivering of new technologies to meet all the customer’s needs.

Our location in Toronto Ontario, Canada provides our clients with the added advantage of North American IP rules and regulations and secure communication and logistics. Our Ukraine – based R&D facilities represented with the Ukrainian Laboratories, that is cooperating with leading Ukrainian research institutions and carries out research work in the format of outsourcing.

We work as a preferred partner to many of the world’s top 10 pharma firms, and hundreds of other companies, providing support with creative solutions for complex technical compound issues. Our scientific knowledge, combined with our research and manufacturing capability, enables us to support chemical processing and production without ever compromising on quality.

Our experience, dedication, and commitment to quality make us an ideal partner for discovery stage research.

Send your request

By clicking "Send your request" you are signing up and accepting our Terms of Service and Privacy policy

Technology Offers on Innoget are directly posted and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.